Kang TB - Search Results

1

Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.

Ju HQ, Lu YX, Wu QN, Liu J, Zeng ZL, Mo HY, Chen Y, Tian T, Wang Y, Kang TB, Xie D, Zeng MS, Huang P, Xu RH. Ju HQ, et al. Among authors: kang tb. Oncogene. 2017 Nov 9;36(45):6282-6292. doi: 10.1038/onc.2017.227. Epub 2017 Jul 10. Oncogene. 2017. PMID: 28692052 Free PMC article.

2

MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.

Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP. Yi C, et al. Oncogene. 2012 Oct 11;31(41):4421-33. doi: 10.1038/onc.2011.629. Epub 2012 Jan 16. Oncogene. 2012. PMID: 22249270

3

MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.

Li YQ, Ren XY, He QM, Xu YF, Tang XR, Sun Y, Zeng MS, Kang TB, Liu N, Ma J. Li YQ, et al. Among authors: kang tb. Cell Death Dis. 2015 Jan 22;6(1):e1618. doi: 10.1038/cddis.2014.582. Cell Death Dis. 2015. PMID: 25611392 Free PMC article.

4

Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.

Mao YP, Zhou GQ, Liu LZ, Guo R, Sun Y, Li L, Lin AH, Zeng MS, Kang TB, Jia WH, Shao JY, Mai HQ, Ma J. Mao YP, et al. Among authors: kang tb. Br J Cancer. 2014 May 27;110(11):2633-9. doi: 10.1038/bjc.2014.243. Epub 2014 May 8. Br J Cancer. 2014. PMID: 24809780 Free PMC article.

5

hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas.

Xu S, Feng Z, Zhang M, Wu Y, Sang Y, Xu H, Lv X, Hu K, Cao J, Zhang R, Chen L, Liu M, Yun JP, Zeng YX, Kang T. Xu S, et al. Oncogene. 2011 May 12;30(19):2219-29. doi: 10.1038/onc.2010.596. Epub 2011 Jan 17. Oncogene. 2011. PMID: 21242961

6

Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer.

Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG, Chi YI, Evers BM, Zhou BP. Dong C, et al. Oncogene. 2013 Mar 14;32(11):1351-62. doi: 10.1038/onc.2012.169. Epub 2012 May 7. Oncogene. 2013. PMID: 22562246 Free PMC article.

7

Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in Escherichia coli and One-Step Chromatographic Purification.

Byun KT, Kim B, Cho J, Lee I, Lee MG, Park D, Kang TB, Won HS, Kim CG. Byun KT, et al. Among authors: kang tb. Biomolecules. 2023 Oct 11;13(10):1508. doi: 10.3390/biom13101508. Biomolecules. 2023. PMID: 37892190 Free PMC article.

8

Doxorubicin covalently conjugated heparin displays anti-cancer activity as a self-assembled nanoparticle with a low-anticoagulant effect.

Lee JH, Yang SB, Lee JH, Lim H, Lee S, Kang TB, Lim JH, Kim YJ, Park J. Lee JH, et al. Among authors: kang tb. Carbohydr Polym. 2023 Aug 15;314:120930. doi: 10.1016/j.carbpol.2023.120930. Epub 2023 Apr 18. Carbohydr Polym. 2023. PMID: 37173028

9

Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy.

Park SH, Lee JH, Yang SB, Lee DN, Kang TB, Park J. Park SH, et al. Among authors: kang tb. Pharmaceutics. 2023 Apr 3;15(4):1131. doi: 10.3390/pharmaceutics15041131. Pharmaceutics. 2023. PMID: 37111617 Free PMC article.

10

Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation.

Kang JH, Lee SB, Seok J, Kim DH, Ma G, Park J, Jeong AJ, Ye SK, Kang TB. Kang JH, et al. Among authors: kang tb. Int J Mol Sci. 2023 Mar 23;24(7):6079. doi: 10.3390/ijms24076079. Int J Mol Sci. 2023. PMID: 37047051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters